Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HyperHAES vs mannitol for intracranial hypertension in traumatic brain injury
2007-002005-45Phase 3Completed
- Sponsor
- Fondazione IRCCS San Gerardo dei Tintori
- Start
- May 2007
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of HyperHAES in intracranial hypertension (IH) and traumatic brain injury (TBI) (2 arms), sponsored by Fondazione IRCCS San Gerardo dei Tintori. Primary endpoint: Intracranial pressure reduction time. Started May 2007; status: completed.
02
Drugs
HyperHAES
03
Conditions
intracranial hypertension (IH)traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2007-002005-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002005-45.